North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Recent Updates - Updated items
All Formulary Amendments
Records 1 to 13 of 13
Details
UPD
sitematrix Changed from 0 to
20/11/2023 12:38:38
(DavidS )
UPD
FurtherInformation Changed from
Approved for untreated acute myeloid leukaemia in line with NICE
to
Approved for untreated acute myeloid leukaemia in line with NICE
20/11/2023 12:38:38
(DavidS )
UPD
Gemtuzumab ozogamicin (Mylotarg
®
) updated
20/11/2023 12:38:38
(DavidS )
UPD
NHSE Changed from
27/07/2022 14:49:31
(DavidS )
UPD
sitematrix Changed from 0 to
27/07/2022 14:49:31
(DavidS )
UPD
BlueTeq Changed from to Y
27/07/2022 14:49:31
(DavidS )
UPD
blackTriangle Changed from to N
27/07/2022 14:49:31
(DavidS )
UPD
isHC Changed from N to Y
27/07/2022 14:49:31
(DavidS )
UPD
FurtherInformation Changed from
Approved for untreated acute myeloid leukaemia in line with NICE
to
Approved for untreated acute myeloid leukaemia in line with NICE
&nb
27/07/2022 14:49:31
(DavidS )
UPD
Gemtuzumab ozogamicin (Mylotarg
®
) updated
27/07/2022 14:49:31
(DavidS )
UPD
Gemtuzumab ozogamicin Published from Draft Mode
30/05/2019 15:39:50
(DavidS )
LDL
Link Added : NICE TA545: Gemtuzumab ozogamicin for untreated acute myeloid leukaemia : https://www.nice.org.uk/guidance/ta545
25/04/2019 14:25:27
(DavidS )
DUP
Gemtuzumab ozogamicin (Mylotarg
®
) added NICE TA545
25/04/2019 14:24:44
(DavidS )